Cargando...
Two-step feature selection for predicting survival time of patients with metastatic castrate resistant prostate cancer
Metastatic castrate resistant prostate cancer (mCRPC) is the major cause of death in prostate cancer patients. Even though some options for treatment of mCRPC have been developed, the most effective therapies remain unclear. Thus finding key patient clinical variables related with mCRPC is an import...
Guardado en:
| Publicado en: | F1000Res |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
F1000Research
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5130083/ https://ncbi.nlm.nih.gov/pubmed/27990267 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.8201.1 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|